|
ASTRO ROCKS: Understanding Reviewers and the Review Process |
- 1.00 Certificate of Attendance
|
Upcoming Webinars |
09/21/2026 to 11/05/2028 |
$0.00 |
|
ASTRO's Authorized User Training Program for Radiopharmaceutical Therapy Application |
|
|
12/09/2025 to 12/31/2026 |
$0.00 |
|
ASTRO-ROI Co-sponsored ROCKS: Funding Opportunities Beyond NIH – Tips and Tricks for Success |
- 1.00 Certificate of Attendance
|
Sessions onDemand |
12/07/2023 to 02/06/2027 |
$0.00 |
|
ASTRO/ILROG Joint Activity: The Comeback of RT – Radiation Therapy is Back in the Frontline of Managing Hodgkin and Indolent Lymphomas |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Sessions onDemand |
06/09/2026 to 06/08/2028 |
$149.00 |
|
ASTRO/JASTRO Joint Session: Advances in Liver Cancer Radiation Therapy |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Sessions onDemand |
02/18/2025 to 02/17/2027 |
$149.00 |
|
ASTRO/KCA Joint Activity: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
05/19/2026 to 05/18/2028 |
$149.00 |
|
ASTRO/SNMMI Joint Session: Unlocking Success in Radiopharmaceutical Therapy: Collaboration between Radiation Oncology, Nuclear Medicine and Industry |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
12/01/2025 to 11/30/2027 |
$149.00 |
|
ASTRO/SNO Joint Activity: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How? |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
|
Sessions onDemand |
01/27/2026 to 01/26/2028 |
$149.00 |
|
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
01/07/2025 to 01/06/2027 |
$149.00 |
|
Best Practices in the Management of Oligometastatic and Oligoprogressive Liver Metastases |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
02/18/2025 to 02/17/2027 |
$149.00 |
|
Best Practices in the Multidisciplinary Management of Borderline Resectable and Unresectable Pancreatic Cancer as well as Extrahepatic/Perihilar... |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
06/17/2025 to 06/16/2027 |
$149.00 |
|
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
12/17/2024 to 12/16/2026 |
$149.00 |
|
Beyond the Beam 2.0: An Updated Radiation Oncology Curriculum for Radiopharmaceutical Therapy |
- 14.00 AMA PRA Category 1 Credit™
- 14.00 Certificate of Attendance
|
Sessions onDemand |
07/31/2026 to 07/30/2028 |
$799.00 |
|
Beyond the First Dose: Re-irradiation for Brain Tumors - Maximizing Outcomes and Managing Risk |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
06/16/2026 to 06/15/2028 |
$149.00 |
|
Brain Metastases Radiotherapy While Mitigating Radionecrosis and Neurotoxicity in a Community Setting |
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
|
Sessions onDemand |
02/25/2025 to 02/24/2027 |
$149.00 |